Provided by Tiger Fintech (Singapore) Pte. Ltd.

Femasys Inc

0.7031
-0.0423-5.67%
Post-market: 0.6054-0.0977-13.90%19:59 EDT
Volume:27.83M
Turnover:21.15M
Market Cap:30.24M
PE:-0.83
High:0.9000
Open:0.7494
Low:0.5600
Close:0.7454
52wk High:1.80
52wk Low:0.3067
Shares:43.01M
Float Shares:38.18M
Volume Ratio:1.38
T/O Rate:72.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8480
EPS(LYR):-0.8450
ROE:-329.45%
ROA:-70.30%
PB:20.06
PE(LYR):-0.83

Loading ...

Femasys Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 11

Femasys Inc. : H.c. Wainwright Cuts Target Price to $8 From $12

THOMSON REUTERS
·
Aug 11

Femasys Inc. Reports 52.4% Sales Increase to $750,532 and Net Loss of $10.48M in First Half of 2025; EPS at ($0.39)

Reuters
·
Aug 09

Press Release: Femasys Announces Second Quarter Financial Results for 2025

Dow Jones
·
Aug 09

BRIEF-Femasys Secures First European Order For Fembloc, Marking Strategic Milestone In Global Expansion

Reuters
·
Aug 06

Femasys Inc. Secures $400,000 Order for FemBloc in Spain, Marking First European Market Entry

Reuters
·
Aug 06

Femasys Secures First European Order for Fembloc, Marking Strategic Milestone in Global Expansion

THOMSON REUTERS
·
Aug 06

Femasys Inc expected to post a loss of 18 cents a share - Earnings Preview

Reuters
·
Aug 05

Femasys Inc. Faces Potential Delisting from Nasdaq Due to Noncompliance with Minimum Bid Price Requirement

Reuters
·
Jul 19

BRIEF-Femasys Files For Mixed Shelf Offering Of Up To $150 Million

Reuters
·
Jul 04

Femasys Inc. Enters Agreement to Sell Up to $10M in Shares to Alumni Capital LP

Reuters
·
Jul 04

Femasys Inc. Files Initial Statement of Beneficial Ownership for Chief Commercial Officer Nicholas Kelley Stinson

Reuters
·
Jul 02

Femasys Inc. Unveils Presentation Highlighting Innovations in Women's Reproductive Health and Strategic Focus Areas

Reuters
·
Jul 02

Femasys Gets Australia, New Zealand Approvals for Two Products

MT Newswires Live
·
Jul 01

Femasys Secures Regulatory Approvals in Australia and New Zealand for Groundbreaking Infertility Solutions FemaSeed and FemVue

Reuters
·
Jul 01

Femasys Inc. Conducted Annual Stockholders Meeting

Reuters
·
Jun 26

Femasys Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 26

Femasys Inc. Achieves European CE Mark Approval for FemBloc®, Pioneering Non-Surgical Permanent Birth Control Solution

Reuters
·
Jun 25

Press Release: Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth

Dow Jones
·
Jun 17

Femasys Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 12